Comprehensive & cost effective laboratory monitoring of HIV/AIDS: An African role model

Journal of Visualized Experiments

Volumn , Issue 44, 2010, Pages

  Lawrie, Denise ^a,b   Janossy, George ^b   Roos, Maarten ^c   Glencross, Deborah K ^a,b  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Lightcurve Films   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80355124314     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2312     Document Type: Article

References (40)

1. UNAIDS Report on the global HIV/AIDS epidemic; ISBN 978 92 9 173711 6.http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp (2008).
2. World Health Organization Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescent. November 2009 http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf (2009).
3. Mugyenyi, P. et al. for the DART group. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomized non-inferiority trial Lancet 375, 123-31 (2009).
4. th Conference on Retroviruses and Opportunistic Infections (2010).
5. th Conference on Retroviruses and Opportunistic Infections (2010).
6. Petti, C. A., Polage, C. R., Quinn, T. C., Ronald, A. R., & Sande, M. A. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 42, 377-82 (2006).
7. Brown, H. Global health: Great expectations. Bmj 334, 874-6 (2007).
8. Crisp, N. Turning the World Upside Down. Royal Society of Medicine Press. ISBN: 978-1853159336. (2009).
9. Hecht, R., Bollinger, L., Stover, J., McGreevey, W., Muhib, F., Madavo, C. E., & de Ferranti, D. Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff. 28, 1591-605 (2009).
10. Lawrie, D., Coetzee, L.M., Glencross, D.K. A model for continuous quality control incorporating sample-to sample assessment of optical alignment, fluorescence sensitivity and volumetric operation flow cytometers. Cytometry B Clin Cytom 78B, 201-8 (2010).
11. Loken, M. R., Brosnan, J. M., Bach, B. A. & Ault, K. A. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11, 453-9 (1990).
12. Glencross, D., Scott, L. E., Jani, I. V., Barnett, D. & Janossy, G. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 50, 69-77 (2002).
13. Glencross, D. K., Janossy, G., Coetzee, L. M., Lawrie, D., Aggett, H. M., Scott, L. E., Sanne, I., McIntyre, J. A., & Stevens, W. Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin Cytom 74 Suppl 1, S40-51 (2008).
14. Dalgleish, A. G. et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-7 (1984).
15. Liu, Z., Cumberland, W. G., Hultin, L. E., Prince, H. E., Detels, R. & Giorgi, J. V. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count. J Acquir Immune Defic Syndr Hum Retrovirol 16, 83-92 (1997).
16. Glencross, D. K., Janossy, G., Coetzee, L. M., Lawrie, D., Scott, L. E., Sanne, I., McIntyre, J. A. & Stevens, W. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom 74 Suppl 1, S131-40 (2008).
17. Coetzee, L. M., Tay, S. S., Lawrie, D., Janossy, G., & Glencross, D. K. From research tool to routine test: CD38 monitoring in HIV patients. Cytometry B Clin Cytom 76, 375-84 (2009).
18. Larsen, C. H. The fragile environments of inexpensive CD4+ T-cell enumeration in the least developed countries: strategies for accessible support. Cytometry B Clin Cytom 74 Suppl 1, S107-16 (2008).
19. Glencross, D.K., Coetzee, L.M., Lawrie, D., Sanne, I., McIntyre, J.A., Janossy, G., & Stevens, W. Longitudinal monitoring of CD38 activation can obviate costly viral load testing in 60% of patients on ART. Poster presentation (2009).
20. Bergeron, M., Lustyik, G., Phaneuf, S., Ding, T., Nicholson, J.K., Janossy, G., Shapiro, H., Barnett, D., & Mandy, F. Stability of currently used cytometers facilitates the identification of pipetting errors and their volumetric operation: "time" can tell all. Cytometry B Clin Cytom 52,:37-9 (2003).
21. Coulter, B. Flow Cytometer Alignment Verification Package insert of Flow-CheckTM Fluorospheres. Volume PN 4276179-LA. Galway: Beckman Coulter USA; (2008).
22. Coulter, B. Flow-SetTM Fluorospheres (Flow Cytometer Standardization Fluorospheres). Package insert of Flow-SetTM Fluorospheres. Volume PN 6607007. Galway: Beckman Coulter USA; (2007).
23. Coulter, B. Immuno-TrolTM Cells. Package insert of Immuno-TrolTM Cells. Volume PN 6607077. Galway: Beckman Coulter USA; (2007).
24. IQAP. Beckman Coulter Hematology IQAP program Volume 2009; (2009).
25. UKNEQAS. United Kingdom National External Quality Assessment Service. (2009).
26. Glencross, D. K., Aggett, H. M., Stevens, W. S., & Mandy, F. African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories. Cytometry B Clin Cytom 74 Suppl 1, S69-79 (2008).
27. Tilling R., Kinloch, S., Goh, L.E. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. Aids 16, 589-96 (2002).
28. Coulter, B. FLOWCARETM PLG CD4 Reagent (CD45-FITC/CD4-PE). Package insert of FLOWCARETM PLG CD4 Reagent. Galway: Beckman Coulter USA; (2004).
29. Coulter, B. Flow-CountTM Fluorospheres. PN 7507992-M. Galway: Beckman Coulter USA; 2007.
30. Scott, L.E., & Glencross, D.K. Monitoring reproducibility of single analysis, single platform CD4 cell counts in a high volume, low resource laboratory setting using sequential bead count rates. Cytometry B Clin Cytom 67, 31-2 (2005).
31. Storie, I., Sawle, A., Goodfellow, K., Whitby, L., Granger, V., Reilly, J.T. & Barnett, D. Flow rate calibration: a new approach for performing absolute cell counts. Cytometry B Clin Cytom 55, 1-7. (2003).
32. Coetzee, L., Lawrie, D., Stevens, W., & Glencross, D.K. Evaluation of pipetting methodology to assess precision and accuracy of single platform PLG/CD4 enumeration. HIV Congress, Durban, 2006.
33. NHLS Training Manual, PLG/CD4 Workshop www.CD4-PLG.net (2008).
34. Borowitz, M. J., Guenther, K. L., Shults, K. E., & Stelzer, G. T. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100, 534-40 (1993).
35. Mokone, G.N., Lawrie, D., Coetzee, L., & Glencross, D.K. Interpretation of CD45 patterns in the PanLeucoGating CD4 test can be used for diagnosis of white cell abnormalities. Poster presentation (2007).
36. Lawrie, D. The wide-spread clinical uses of PanLeucoGating technology in the HIV diagnosis oriented immunohaematology laboratory. PhD Thesis (in preparation).
37. Badri, M., Lawn, S. D., & Wood, R. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting. BMC Infect Dis; 8: 89. (2008).
38. Peter, T., Badrichani, A., Wu, E., Freeman, R., Ncube, B., Ariki, F., Daily, J., Shimada, Y., & Murtagh, M. Challenges in implementing CD4 testing in resource-limited settings. Cytometry B. Clin Cytom 74 Suppl 1, S123-30 (2008).
39. Denny, T. N., Gelman, R., Bergeron, M., Landay, A., Lam, L., Louzao, R., Mandy, F. F., Schmitz, J., Spira, T., Wilkening, C., & Glencross, D. K. A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study. Cytometry B Clin Cytom 74 Suppl 1, S52-64 (2008).
40. Janossy, G. The changing pattern of "smart" flow cytometry (S-FC) to assist the cost-effective diagnosis of HIV, tuberculosis, and leukemias in resource-restricted conditions. Biotechnol J 3, 32-42 (2008).